InvestorsHub Logo

Coldsuite

05/23/20 7:13 PM

#79819 RE: ScienceOC #79818

Hello all....new to the board. I live in the Greatland and from up here it appears that we may have an amazing stock on our hands. I am quite impressed with NP, his passion and commitment to the company on our behalf. Dr Patterson, although not a part of Cytodyne, is an outstanding individual who provides the world a great view of what he and his team have discovered. I have owned a number of "Can't miss" stocks over the years and most have not fared well. I am about even I guess. I am impressed with the smart folks on this board concerning Cytodyne and hope that we all fare well. Be safe and when this is over.....next year, I too will meet all in Portland or Vegas. Good luck.

BioInvestor4

05/23/20 7:13 PM

#79820 RE: ScienceOC #79818

Good news for Leronlimab! Bad news for the poor soles taking this “standard of care”!

JennyBuns

05/23/20 7:18 PM

#79822 RE: ScienceOC #79818

HI !!

I am trying to do my research and follow the good information here. Is this the same trial that the monitoring group recommended early unblinding and giving Remdesivir to those in the placebo group for ethical reasons?

And isn't this the same trial they ended early, as some people call by "moving the goal posts", because of the unblinding? Didn't that have the effect of ignoring the end point mortality?

I'm trying to get smart on this as Black-Ops so graciously suggested.

GTLA !!

J.

<3

TheBioTechG

05/23/20 7:30 PM

#79824 RE: ScienceOC #79818

This shouldn’t surprise too many people. Didn’t they stop an Ebola-remdesivir trial because of this exact reason?